Title:
COMPOSITION CONTAINING N-CARBAMYL-L-GLUTAMIC ACID FOR TREATMENT OF INFLAMMATORY DISEASES
Document Type and Number:
WIPO Patent Application WO/2023/167563
Kind Code:
A1
Abstract:
The present invention relates to a method for biosynthesizing N-carbamyl-L-glutamic acid and a novel use thereof for the prevention or treatment of inflammatory diseases. The invention also relates to a composition for the prevention, amelioration or treatment of inflammatory bowel disease, which contains N-carbamyl-L-glutamic acid as an active ingredient, thereby minimizing the side effects of existing treatments for inflammatory bowel disease and securing stability.
Inventors:
SON MI-YOUNG (KR)
PARK DOO-SANG (KR)
LEE HANA (KR)
CHOI EUNHO (KR)
PARK DOO-SANG (KR)
LEE HANA (KR)
CHOI EUNHO (KR)
Application Number:
PCT/KR2023/002981
Publication Date:
September 07, 2023
Filing Date:
March 03, 2023
Export Citation:
Assignee:
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR)
International Classes:
C12P13/14; A23K20/142; A23L33/135; A23L33/175; A61K31/198; A61P1/00; A61P1/04; A61P29/00; C12N1/20
Foreign References:
| KR20210158357A | 2021-12-30 | |||
| KR20150027152A | 2015-03-11 | |||
| KR20110019058A | 2011-02-25 | |||
| KR20110051268A | 2011-05-17 | |||
| US20100055082A1 | 2010-03-04 |
Attorney, Agent or Firm:
BAE, KIM & LEE IP (KR)
Download PDF: